Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Elite Pharmaceuticals Inc (OTCQB:ELTP)

0.09
Delayed Data
As of Dec 15
 0.00 / 0.00%
Today’s Change
0.06
Today|||52-Week Range
0.25
-40.79%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Revenue and IncomeNet Revenues2.3M1.4M1.7M1.6M
 
 
 
 
 
Cost of Goods Sold1.6M142.4K837.3K211.5K
 
 
 
 
 
Depreciation And Amortization166.6K195.4K184.6K410.6K
 
 
 
 
 
 
Operating ExpensesGross Income582.9K1.0M680.9K1.0M
 
 
 
 
 
General Expenses2.3M4.1M2.9M3.1M
 
 
 
 
 
Research And Development1.5M4.0M2.0M2.5M
 
 
 
 
 
Total Operating Expenses4.1M4.4M3.9M3.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-1.7M-3.1M-2.2M-2.1M
 
 
 
 
 
Extraordinary Credit1.6M56.8K139.3K4.0M
 
 
 
 
 
Interest Expense On Debt55.6K56.3K70.7K82.5K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-203.4K-3.2M-2.2M1.8M
 
 
 
 
 
Income Taxes-1.9M-2.5K-3.0K0.00
 
 
 
 
Net Income1.7M-3.2M-2.2M1.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS904.8M927.9M819.3M782.4M
 
 
 
 
 
Shares To Calculate EPS Diluted910.5M927.9M819.3M782.4M
 
 
 
 
 
 
Earnings Per ShareEPS$0.00-$0.01$0.00$0.00
 
 
EPS Diluted$0.00-$0.00-$0.00$0.00